NCT04838691

Brief Summary

This study aims to test the effectiveness of interpersonal counseling in PMS symptom management in university students experiencing PMS symptoms.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 6, 2020

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 6, 2020

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2020

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

April 3, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 9, 2021

Completed
Last Updated

April 9, 2021

Status Verified

April 1, 2021

Enrollment Period

1 month

First QC Date

April 3, 2021

Last Update Submit

April 8, 2021

Conditions

Keywords

premenstrual syndromeinterpersonal counseling

Outcome Measures

Primary Outcomes (1)

  • Premenstrual Symptom Screening Tool

    Women will be divided into 3 different groups as a result of the points they get from PSST. The first group will consist of women who fully meet the PMDD criteria. These Women must have at least one of the four main symptom groups from the group A symptoms plus any of the 4 symptoms marked as moderate to severe on the instrument. In addition, he should have reported that at least one of the questions in group B was severe, and yes answers should be given to both questions in group C.The second group is the group that meets the PMS living criteria. These women are expected to have marked at least one of the 4 main symptoms as moderate to severe from the group A questions and any other 4 symptoms as moderate to severe to answer the group B questions as moderate to severe, and to answer yes to at least one question from the C group.The third group will be considered as the group with subthreshold symptoms consisting of those who do not meet the criteria for entering the other two groups.

    Baseline (beginning), Change from Baseline PMDD or PMS after 2 months, Change from Baseline PMDD or PMS after 5 months,

Secondary Outcomes (2)

  • Scale Of Interpersonal Relatıonshıps Dımensıons

    Baseline (beginning), Change from Baseline Sub-dimensions of Interpersonal Relationships Scale after 2 months, Change from Baseline Sub-dimensions of Interpersonal Relationships Scale after 5 months

  • Perceived stress scale

    Baseline (beginning), 2 months after beginning, 3 months after beginning

Study Arms (2)

interpersonal relations counseling applied

EXPERIMENTAL

8 sessions of interpersonal relations counseling, each lasting 40 minutes, were applied for 2.

Behavioral: interpersonal counseling

no application

NO INTERVENTION

No action taken.

Interventions

In the intervention group, it will be administered for 40 minutes for 8 weeks to people with symptoms of premenstrual syndrome.

interpersonal relations counseling applied

Eligibility Criteria

Age18 Years - 30 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailswomen
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • According to the Pre-menstrual Symptom Screening Instrument, which is located in the group living with AES (Pre-Mental Syndrome)
  • between the ages of 18-30
  • Menstruating at regular intervals for at least 2 years (21-35 days)
  • Those who have never given birth
  • Speak and understand Turkish
  • It will consist of people who have not received antidepressant, oral contraceptive or hormone therapy for any reason.

You may not qualify if:

  • Having a known gynecological disease (endometriosis, polycystic ovary, ...)
  • A known, ongoing physical health problem (diabetes, rheumatic disease, ...)
  • Any psychiatric disease diagnosed (psychotic disorder, mood disorder, anxiety disorder ...)
  • People who use cigarettes, alcohol or substances

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul University-Cerrahpasa

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Premenstrual Syndrome

Condition Hierarchy (Ancestors)

Menstruation DisturbancesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Neslihan Özcan, Professor

    Istanbul University - Cerrahpasa

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

April 3, 2021

First Posted

April 9, 2021

Study Start

April 6, 2020

Primary Completion

May 6, 2020

Study Completion

August 30, 2020

Last Updated

April 9, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Sharing is considered inappropriate before the end of the study.

Locations